Starsource Multitrade

Starsource Multitrade P/FCF

De K/VKS (Koers-vrije kasstroom-verhouding) van Starsource Multitrade (506365.BO) per 16 okt 2026 bedraagt -1,60. In het voorgaande jaar bedroeg K/VKS (Koers-vrije kasstroom-verhouding) -60,08 — een verandering van -97,34% (hoger).

P/FCF

-1,60

YoY

-97,34%

Laatst bijgewerkt:

K/VKS (Koers-vrije kasstroom-verhouding) van Starsource Multitrade is 2026 -1,60 . K/VKS (Koers-vrije kasstroom-verhouding) van Starsource Multitrade was 2025 -60,08 . Het is daarmee -97,34% hoger lager dan het jaar ervoor.

De Starsource Multitrade P/FCF historie

  • 3 jaar

  • 10 jaar

  • 25 jaar

  • Max

P/FCF
Datum
P/FCF
1 jan 2019
-20,89 INR
1 jan 2020
3,51 INR
1 jan 2021
-41,56 INR
1 jan 2022
-51,65 INR
1 jan 2023
-24,83 INR
1 jan 2024
23,45 INR
1 jan 2025
-60,08 INR
1 jan 2026
-1,60 INR
De Starsource Multitrade P/FCF historie
JAARP/FCFYoY
-1,60-97,34%
-60,08-356,20%
23,45-194,45%
-24,83-51,92%
-51,65+24,28%
-41,56-1.283,40%
3,51-116,81%
-20,89+104,51%
-10,22-485,87%
2,65-132,63%
-8,11-97,56%
-332,30+224,19%
-102,50—

Deze data ophalen via de Eulerpool API

100.000 requests/maand gratis · geen creditcard

Starsource Multitrade Aandelenanalyse

Wat doet Starsource Multitrade? Starsource Multitrade Ltd, identified by the ticker symbol 506365.BO and ISIN INE320M01019, is a corporate entity registered in India with its headquarters located in Mumbai, Maharashtra. The company was originally established through an initial public offering on January 2, 1995. While the specific sector and industry classifications are currently listed as not applicable, the company's operational history and strategic direction are closely tied to its former identity as Chemo Pharma Laboratories Ltd. This previous incarnation operated within the pharmaceutical industry, focusing on the development and distribution of healthcare products. However, the corporate landscape has shifted significantly, and the entity is no longer engaged in its original pharmaceutical activities. According to available information, the firm currently has no active operations within its traditional business lines. Instead, the organization is in a transitional phase, actively exploring new business opportunities to redefine its market presence. The strategic intent of the current management is to pivot away from pharmaceuticals and acquire businesses in the power and chemicals sectors. This move represents a substantial change in the company's core focus, aiming to diversify its portfolio and enter entirely different industrial segments. The company's official website, https://www.thechemopharmalaboratoriesltd.com/, reflects its historical branding, although the operational reality has evolved. Investors and stakeholders monitoring the company should note that the absence of current operations means that recent financial performance may not reflect traditional revenue streams associated with pharmaceutical manufacturing or sales. The focus is currently on strategic acquisitions and business development rather than organic growth from existing products. The transition from a pharmaceutical manufacturer to a holding or investment vehicle targeting power and chemical assets suggests a long-term restructuring plan. Until new acquisitions are finalized and integrated, the company remains in a state of exploration and preparation. The headquarters in Mumbai serves as the administrative center for these strategic discussions and future operational planning. The lack of a defined sector classification further underscores the company's current status as an entity in flux, waiting for new business units to be acquired and operationalized. This profile highlights the significant shift from its historical roots in healthcare to its current ambitions in energy and industrial chemicals, marking a distinct chapter in the company's corporate evolution. Starsource Multitrade is een van de meest populaire bedrijven op Eulerpool.

Veelgestelde vragen over het aandeel Starsource Multitrade

K/VKS (Koers-vrije kasstroom-verhouding) van Starsource Multitrade bedraagt -1,60 in 2026.

K/VKS (Koers-vrije kasstroom-verhouding) van Starsource Multitrade is veranderd van -60,08 naar -1,60, wat een verandering van -97,34% vertegenwoordigt. De waarde is hoger dan het vorige jaar.

Op Eulerpool vindt u de volledige historische ontwikkeling van K/VKS (Koers-vrije kasstroom-verhouding) Starsource Multitrade sinds 2006 – met jaarlijkse waarden, grafieken en gedetailleerde analyse.

De koers-vrije kasstroom-verhouding meet hoeveel beleggers betalen voor elke eenheid vrije kasstroom. Een lagere ratio kan een betere waarde aangeven.

K/VKS = Marktkapitalisatie / Vrije kasstroom

Om van K/VKS (Koers-vrije kasstroom-verhouding) te evalueren, is het essentieel dit te vergelijken met andere bedrijven in dezelfde sector. Op Eulerpool kunt u maatstaven direct vergelijken.

Een 'goede' varieert per branche en bedrijfsfase. Op Eulerpool kunt u maatstaven direct vergelijken.

Deze data ophalen via de Eulerpool API

100.000 requests/maand gratis · geen creditcard

Waardering — Starsource Multitrade

Alle kengetallen — Starsource Multitrade